BioPharm America™: MassBio to host partnering event
MassBio, in partnership with EBD Group, the leading partnering firm for the life sciences industry, will hold the fifth annual BioPharm America™ conference September 19–21 at the Westin Boston Waterfront.
“BioPharm America is a highly productive partnering event, and as the leading advocate for Massachusetts’ life sciences supercluster, MassBio hopes to continue providing value to our member community through engagement with this year’s event,” said Robert K. Coughlin, President & CEO of MassBio.
BioPharm America has become a major hub for engaging new partners in the life sciences industry. The event attracts the world’s top dealmakers from biotech and pharma, as well as leading bankers and VCs. Powered by EBD Group’s sophisticated partnering system, partneringONE®, the event enables delegates to efficiently start partnerships with companies across the life sciences value chain.
“Boston is a major life science sector, and this partnering event consistently brings together the ‘who’s who’ of professionals from leading companies,” said Carola Schropp, President of EBD Group. “The event continues to grow, due in large part to our collaboration with MassBio and the enthusiasm of their members. Like our other partnering events, BioPharm America is designed to provide delegates with direct access to high level dealmakers from a wide range of companies.”
By posing the question “Who is the best player in the value chain: Is biotech really better at research?” this year’s plenary is intended to spark a lively discussion. The Wednesday afternoon program is split into two tracks—the Business Development track and the In the Spotlight track.
While the Business Development track is geared primarily toward industry investing strategies, from new trends in pharma/venture funds to financing models for creative exit strategies, the In the Spotlight track focuses on prevailing current topics of interest such as pre-competitive collaborations and emerging markets.
The Thursday keynote “From start-up to commercial company and the challenges in between: Could we do it again today?” will be of special interest to start-up companies, and features panelists from Organogenesis, Genzyme, Alkermes plc and others. Roundtable discussions on molecular diagnostics, open innovation and infectious disease are also planned.
In 2011, BioPharm America saw more than 950 international biotech and pharma leaders from 588 companies engage in 2,550 partnering meetings. There were 34 countries represented and 760 licensing opportunities posted on partneringONE.
MassBio members will receive an additional discount of $200 off of registration. MassBio members registering before July 20th will save $400 ($200 early bird, $200 member discount).
Registration information for BioPharm America can be found online at http://www.ebdgroup.com/bpa.
Early stage projects, innovative start-ups, established biotechs and midsize pharma
companies seeking international partnerships are invited to present. Inquiries should be
sent to Christina Kirsch directly at email@example.com.